Loading
Orchard Therapeutics plc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Gaspar Bobby, was filed 05 Apr 2022.
Orchard Therapeutics plc: what insiders have been doing
Orchard Therapeutics plc is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). Orchard Therapeutics plc has had no insider filing for more than a year; the last one goes back to 24 January 2024.
Over the whole record (from 2020), the tally stands at 15 purchases and 4 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
36
Thresholds
n/a
Buy Volume
€3M
15 ops. · all time
Sell Volume
€6M
4 ops. · all time
Since the insiders bought
- -22.4%Entry 53.50 · Close at T+365 41.50
- -26.2%Entry 53.50 · Close at T+365 39.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
Revenue20.2M
Net income-134.1M-665.0% margin
Last declaration on 24 January 2024
Declarations36 total
92,081 sharesOrdinary SharesSEC:0000950170-24-007078:0
366,158 sharesOrdinary SharesSEC:0000950170-24-007058:0
12,294 sharesOrdinary SharesSEC:0000950170-24-007074:0
44,391 sharesOrdinary SharesSEC:0000950170-24-007087:0
37,179 sharesOrdinary SharesSEC:0000950170-24-007057:0
9,294 sharesOrdinary SharesSEC:0000950170-24-007064:0
20,000 shares@ US$0.459136.2% of flowOrdinary SharesSEC:0001209191-23-018327:0
20,000 shares@ US$0.459135.7% of flowOrdinary SharesSEC:0001209191-23-008578:0
15,000 shares@ US$0.739100.0% of flowOrdinary SharesSEC:0001209191-22-022988:0
Canonical exit: 30 Jun 2022 (T+90)
10,000 shares@ US$0.747428.1% of flowOrdinary SharesSEC:0001209191-22-022336:0
Canonical exit: 30 Jun 2022 (T+90)
409,852 sharesOrdinary sharesSEC:0000315066-21-001396:0
409,852 sharesOrdinary sharesSEC:0000315066-21-001396:1
1,022,755 shares@ US$6.9897.2% of flowOrdinary sharesSEC:0000315066-21-001393:0
10,000 shares@ US$2.4423.4% of flowOrdinary SharesSEC:0001209191-21-006430:0
10,667 shares0Ordinary SharesSEC:0001209191-21-003254:0
3,706 shares@ US$6.7223.7% of flowOrdinary SharesSEC:0001209191-21-003254:1
3,411 shares@ US$6.7221.7% of flowOrdinary SharesSEC:0001209191-21-003252:1
6,250 shares0Ordinary SharesSEC:0001209191-21-003252:0
14,570 shares@ US$4.751.9% of flowOrdinary sharesSEC:0001104659-20-122542:0
Canonical exit: 8 Nov 2020 (T+90)
6,787 shares@ US$4.710.9% of flowOrdinary sharesSEC:0001104659-20-122542:1
Canonical exit: 8 Nov 2020 (T+90)
16,291 shares@ US$4.742.2% of flowOrdinary sharesSEC:0001104659-20-122542:2
Canonical exit: 10 Nov 2020 (T+90)
13,031 shares@ US$4.741.7% of flowOrdinary sharesSEC:0001104659-20-122542:3
Canonical exit: 12 Nov 2020 (T+90)
8,235 shares@ US$4.741.1% of flowOrdinary sharesSEC:0001104659-20-122542:4
Canonical exit: 15 Nov 2020 (T+90)
45,249 shares@ US$4.725.9% of flowOrdinary sharesSEC:0001104659-20-122542:5
Canonical exit: 16 Nov 2020 (T+90)
55,204 shares@ US$4.697.2% of flowOrdinary sharesSEC:0001104659-20-122542:6
Canonical exit: 17 Nov 2020 (T+90)
25 of 36 declarations
About Orchard Therapeutics plc
Orchard Therapeutics plc is a biopharmaceutical company focused on developing gene therapies for rare diseases. It is listed on NASDAQ under the ticker symbol ORTX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
